BBNX vs IRMD: stock comparison and AI forecast
Beta Bionics, Inc. (BBNX) and Iradimed Corp (IRMD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BBNX Beta Bionics, Inc.
- Price
- $15.90 +55.6% · 6M
- Market Cap
- $821M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
IRMD Iradimed Corp
- Market Cap
- $981M
- P/E Ratio
- 41.9x
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- IRMD is 1.2 times larger than BBNX by market capitalization ($981M against $821M).
- IRMD turns 26.9% of its revenue into net income, against -65.3% for BBNX.
- IRMD carries 0.14 times debt per unit of equity, against 0.11 times for BBNX.
- IRMD yields 1.65% in dividends; BBNX pays none.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BBNX | IRMD |
|---|---|---|
| Market Cap | $821M | $981M |
| P/E Ratio | – | 41.89x |
| P/B Ratio | 2.05x | 9.21x |
| Dividend Yield | – | 1.65% |
| EPS | $-2.14 | $1.83 |
| Book Value/Share | $7.38 | $8.33 |
| Revenue/Share | $2.34 | $6.99 |
| FCF/Share | $-1.21 | $2.04 |
Profitability & Margins
| Metric | BBNX | IRMD |
|---|---|---|
| ROE | -20.7% | 22.5% |
| ROA | -18.7% | 19.8% |
| ROIC | -22.5% | 26.1% |
| Gross Margin | 58.6% | 75.5% |
| Operating Margin | -72.8% | 32.3% |
| Net Margin | -65.3% | 26.9% |
| EBT Margin | -72.8% | 34.8% |
| Tax Rate | – | 22.9% |
Financial Health
| Metric | BBNX | IRMD |
|---|---|---|
| Current Ratio | 8.92x | 8.99x |
| Quick Ratio | 8.22x | 7.68x |
| D/E Ratio | 0.11x | 0.14x |
| Financial Leverage | 1.11x | 1.14x |
| Working Capital | $260M | $82M |
Cash Flow
| Metric | BBNX | IRMD |
|---|---|---|
| Operating Cash Flow | -$59M | $27M |
| Free Cash Flow | -$66M | $26M |
| Capital Spending | -$7M | -$1M |
| OCF Growth YoY | – | 8.6% |
| FCF Growth YoY | – | 77.2% |
| FCF/Sales | -51.8% | 29.3% |
| CapEx/Sales | 5.2% | 1.1% |
Operational Efficiency
| Metric | BBNX | IRMD |
|---|---|---|
| Asset Turnover | 0.29x | 0.74x |
| Receivables Turnover | 6.2x | 6.5x |
| Inventory Turnover | 2.3x | 1.6x |
| Fixed Assets Turnover | 10.8x | 3.7x |
| Days Sales Outstanding | 59 days | 56 days |
| Days Inventory | 159 days | 225 days |
| Payables Period | 32 days | 40 days |
| Cash Conversion Cycle | 186 days | 241 days |
Income Statement
| Metric | BBNX | IRMD |
|---|---|---|
| Total Revenue | $127M | $89M |
| Operating Income | -$93M | $29M |
| Net Income | -$83M | $24M |
| R&D Expense | $43M | $3M |
| SG&A Expense | $179M | $41M |
| Cost of Goods Sold | $53M | $22M |
Dividend & Shareholder Information
| Metric | BBNX | IRMD |
|---|---|---|
| Dividends Per Share | – | $1.27 |
| Payout Ratio | – | 69.4% |
| Shares Outstanding | 54M | 13M |
| Net Income Growth | – | 10.0% |
| EPS Growth | – | 19.6% |
BBNX vs IRMD: stock comparison and AI forecast
Which is bigger, BBNX or IRMD?
IRMD is 1.2 times larger than BBNX by market capitalization ($981M against $821M).
Which one does Intratio's AI model rank higher, BBNX or IRMD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.